CR20110095A - Derivados biciclicos [3.1.0] como inhibidores del transportador de glicina (divisional solicitud 8333) - Google Patents
Derivados biciclicos [3.1.0] como inhibidores del transportador de glicina (divisional solicitud 8333)Info
- Publication number
- CR20110095A CR20110095A CR20110095A CR20110095A CR20110095A CR 20110095 A CR20110095 A CR 20110095A CR 20110095 A CR20110095 A CR 20110095A CR 20110095 A CR20110095 A CR 20110095A CR 20110095 A CR20110095 A CR 20110095A
- Authority
- CR
- Costa Rica
- Prior art keywords
- glycine
- inhibitors
- conveyor
- divisional application
- bicycle derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a aminas bicíclicas (3.1.0) y a composiciones farmacéuticas que las contienen y a su uso en el tratamiento de trastornos del sistema nervioso central, trastornos cognitivos, esquizofrenia, demencia y otros trastornos en los mamíferos, incluyendo los seres humanos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51084603P | 2003-10-14 | 2003-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20110095A true CR20110095A (es) | 2011-03-09 |
Family
ID=34465157
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8333A CR8333A (es) | 2003-10-14 | 2006-04-06 | Derivados biciclicos [3.1.0 ] como inhibidores del transportador de glicina |
CR20110095A CR20110095A (es) | 2003-10-14 | 2011-02-17 | Derivados biciclicos [3.1.0] como inhibidores del transportador de glicina (divisional solicitud 8333) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8333A CR8333A (es) | 2003-10-14 | 2006-04-06 | Derivados biciclicos [3.1.0 ] como inhibidores del transportador de glicina |
Country Status (26)
Country | Link |
---|---|
US (1) | US7473787B2 (es) |
EP (1) | EP1680124B1 (es) |
JP (2) | JP4732354B2 (es) |
KR (1) | KR20060095865A (es) |
CN (2) | CN1867338A (es) |
AP (1) | AP2006003592A0 (es) |
AU (1) | AU2004281794B2 (es) |
BR (1) | BRPI0415356A (es) |
CA (1) | CA2542279C (es) |
CR (2) | CR8333A (es) |
DK (1) | DK1680124T3 (es) |
EA (1) | EA009903B1 (es) |
EC (1) | ECSP066504A (es) |
ES (1) | ES2634841T3 (es) |
GE (1) | GEP20104959B (es) |
IL (1) | IL174299A (es) |
IS (1) | IS8355A (es) |
MA (1) | MA28094A1 (es) |
MX (1) | MXPA06004279A (es) |
NO (1) | NO337361B1 (es) |
NZ (1) | NZ546012A (es) |
RS (1) | RS20060190A (es) |
TN (1) | TNSN06109A1 (es) |
UA (1) | UA86037C2 (es) |
WO (1) | WO2005037216A2 (es) |
ZA (1) | ZA200602174B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1680124B1 (en) * | 2003-10-14 | 2017-05-31 | Pfizer Products Inc. | Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
GB0408772D0 (en) * | 2004-04-20 | 2004-05-26 | Glaxo Group Ltd | Compounds |
GB0408774D0 (en) * | 2004-04-20 | 2004-05-26 | Glaxo Group Ltd | Compounds |
MX2007000015A (es) * | 2004-06-22 | 2007-03-07 | Schering Corp | Ligandos de receptor de canabinoide. |
CA2603939C (en) | 2005-04-08 | 2013-08-27 | Pfizer Products Inc. | Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
WO2007053499A2 (en) | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of ccr2 |
US8067457B2 (en) | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
WO2007135527A2 (en) * | 2006-05-23 | 2007-11-29 | Pfizer Products Inc. | Benzimidazolyl compounds |
WO2008065500A2 (en) * | 2006-11-30 | 2008-06-05 | Pfizer Products Inc. | Heteroaryl amides as type i glycine transport inhibitors |
DK2247589T3 (da) * | 2007-11-05 | 2013-01-21 | Merck Patent Gmbh | 7-azaindolderivater som selektive 11-beta-hydroxysteroid-dehydrogenase type 1-inhibitorer |
AU2009324479A1 (en) * | 2008-12-12 | 2011-06-30 | Vanderbilt Universtiy | 3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same |
MX2011006845A (es) * | 2008-12-29 | 2011-08-04 | Univ Vanderbilt | Inhibidores de glyt1 biciclicos 3.1.0 y metodos para elaboracion y utilizacion de los mismos. |
FR2944283B1 (fr) * | 2009-04-14 | 2011-05-06 | Sanofi Aventis | Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique |
JPWO2010107115A1 (ja) * | 2009-03-19 | 2012-09-20 | 大正製薬株式会社 | グリシントランスポーター阻害物質 |
TW201225957A (en) | 2010-09-17 | 2012-07-01 | Taisho Pharmaceutical Co Ltd | Glycine transporter inhibitor |
JP2013542929A (ja) | 2010-09-28 | 2013-11-28 | パナセア バイオテック リミテッド | 新規ビシクロ環化合物 |
US9012489B2 (en) | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
US9371282B2 (en) | 2013-05-17 | 2016-06-21 | Centrexion Therapeutics Corporation | Somatostatin receptor subtype 4 (SSTR4) agonists |
CN103319645B (zh) * | 2013-05-31 | 2016-08-10 | 南京洁雅新材料有限公司 | 一种水性金属保护剂及其生产工艺 |
JP6581111B2 (ja) * | 2014-04-28 | 2019-09-25 | メッドシャイン ディスカバリー インコーポレイテッド | Rhoキナーゼ阻害剤としてのイソキノリンスルホン誘導体 |
WO2017049177A1 (en) | 2015-09-16 | 2017-03-23 | Metacrine, Inc. | Farnesoid x receptor agonists and uses thereof |
SG10202110242YA (en) | 2015-09-16 | 2021-10-28 | Metacrine Inc | Farnesoid x receptor agonists and uses thereof |
WO2017049176A1 (en) * | 2015-09-16 | 2017-03-23 | Metacrine, Inc. | Farnesoid x receptor agonists and uses thereof |
US10626081B2 (en) | 2015-09-16 | 2020-04-21 | Metacrine, Inc. | Farnesoid X receptor agonists and uses thereof |
CN113784966A (zh) * | 2019-05-01 | 2021-12-10 | 勃林格殷格翰国际有限公司 | Glyt1抑制剂的固体形式 |
TW202108559A (zh) | 2019-05-31 | 2021-03-01 | 美商醫肯納腫瘤學公司 | Tead抑制劑及其用途 |
US11274082B2 (en) | 2019-05-31 | 2022-03-15 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
TW202400577A (zh) | 2021-09-14 | 2024-01-01 | 美商美國禮來大藥廠 | Sstr4促效劑鹽 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1471055A1 (en) * | 1996-03-29 | 2004-10-27 | Pfizer Inc. | 6-phenylpyridyl-2-amine derivatives |
CA2619901A1 (en) | 1996-05-31 | 1997-12-04 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
DE60206154T2 (de) * | 2001-04-17 | 2006-06-29 | Merck & Co., Inc. | Bicyclo[3,1,0]hexan als strukturelement enthaltende oxazolidinon-antibiotika und deren derivate |
JP4155522B2 (ja) * | 2001-10-22 | 2008-09-24 | ファイザー・プロダクツ・インク | オピオイド受容体アンタゴニストとしての3−アザビシクロ(3.1.0)ヘキサン誘導体 |
EP1442018A1 (en) | 2001-10-31 | 2004-08-04 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Novel anticancer compounds |
GB0130696D0 (en) * | 2001-12-21 | 2002-02-06 | Smithkline Beecham Plc | Chemical Compounds |
MXPA05000434A (es) * | 2002-07-08 | 2005-04-19 | Ranbaxy Lab Ltd | Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico. |
DE60231341D1 (de) * | 2002-08-23 | 2009-04-09 | Ranbaxy Lab Ltd | Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten |
CN100436414C (zh) * | 2003-04-11 | 2008-11-26 | 兰贝克赛实验室有限公司 | 作为毒蕈碱受体拮抗剂的氮杂双环衍生物 |
EP1680124B1 (en) * | 2003-10-14 | 2017-05-31 | Pfizer Products Inc. | Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
MXPA06004278A (es) * | 2003-10-16 | 2006-06-28 | Pfizer Prod Inc | Preparacion de derivados de 3-azabiciclo [3.1.0]hexano. |
KR101347830B1 (ko) | 2004-05-23 | 2014-01-07 | 에이치엠아이, 인코포레이티드 | 테라뮤틴 조절물질 |
-
2004
- 2004-10-14 EP EP04795270.0A patent/EP1680124B1/en active Active
- 2004-10-14 EA EA200600513A patent/EA009903B1/ru not_active IP Right Cessation
- 2004-10-14 NZ NZ546012A patent/NZ546012A/en not_active IP Right Cessation
- 2004-10-14 DK DK04795270.0T patent/DK1680124T3/en active
- 2004-10-14 ES ES04795270.0T patent/ES2634841T3/es active Active
- 2004-10-14 WO PCT/US2004/034083 patent/WO2005037216A2/en active Application Filing
- 2004-10-14 CN CNA2004800300443A patent/CN1867338A/zh active Pending
- 2004-10-14 MX MXPA06004279A patent/MXPA06004279A/es active IP Right Grant
- 2004-10-14 GE GEAP20049350A patent/GEP20104959B/en unknown
- 2004-10-14 AP AP2006003592A patent/AP2006003592A0/xx unknown
- 2004-10-14 BR BRPI0415356-1A patent/BRPI0415356A/pt not_active IP Right Cessation
- 2004-10-14 CA CA2542279A patent/CA2542279C/en not_active Expired - Fee Related
- 2004-10-14 CN CN201010128454A patent/CN101838271A/zh active Pending
- 2004-10-14 JP JP2006535348A patent/JP4732354B2/ja not_active Expired - Fee Related
- 2004-10-14 KR KR1020067007132A patent/KR20060095865A/ko active IP Right Grant
- 2004-10-14 US US10/964,931 patent/US7473787B2/en active Active
- 2004-10-14 AU AU2004281794A patent/AU2004281794B2/en not_active Ceased
- 2004-10-14 RS YUP-2006/0190A patent/RS20060190A/sr unknown
- 2004-10-14 UA UAA200604173A patent/UA86037C2/ru unknown
-
2006
- 2006-03-13 IL IL174299A patent/IL174299A/en active IP Right Grant
- 2006-03-15 ZA ZA2006/02174A patent/ZA200602174B/en unknown
- 2006-03-16 IS IS8355A patent/IS8355A/is unknown
- 2006-04-06 CR CR8333A patent/CR8333A/es unknown
- 2006-04-12 EC EC2006006504A patent/ECSP066504A/es unknown
- 2006-04-14 TN TNP2006000109A patent/TNSN06109A1/fr unknown
- 2006-04-14 MA MA28935A patent/MA28094A1/fr unknown
- 2006-05-15 NO NO20062193A patent/NO337361B1/no not_active IP Right Cessation
-
2011
- 2011-01-28 JP JP2011016751A patent/JP2011157358A/ja active Pending
- 2011-02-17 CR CR20110095A patent/CR20110095A/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20110095A (es) | Derivados biciclicos [3.1.0] como inhibidores del transportador de glicina (divisional solicitud 8333) | |
HN2006013804A (es) | Heteroalrilamidas[3.1.0]biciclicas como inhibidores del trasporte de glicina de tipo i | |
ECSP066391A (es) | [1,8] naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
ECSP056019A (es) | 2,4-di(fenilamino)pirimidinas útiles en el tratamiento de enfermedades neoplásicas, trastornos inflamatorios y del sistema inmune | |
BR0314393A (pt) | Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia | |
PA8615701A1 (es) | Derivados de dihidrobenzofuranilo alcanamina y metodos para su uso. | |
ECSP055780A (es) | Derivados de indol utiles para el tratamiento de enfermedades | |
SV1998000029A (es) | Compuestos de pirazina ref. pg3186 | |
UY28150A1 (es) | Agentes terapeuticos | |
ECSP066962A (es) | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central | |
BR0308937A (pt) | Compostos imidazo fundidos | |
DOP2005000022A (es) | "derivados tetrahidroisoquinolinilo de quinazolina e isoquinolina" | |
UY28144A1 (es) | Agentes terapéuticos | |
ES2178668T4 (es) | Naftilamidas como agentes del sistema nervioso central. | |
BRPI0415769A (pt) | alcanaminas de diidrobenzofuranila e composições farmacêuticas contendo-as | |
PA8583601A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
PA8457001A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol | |
UY27998A1 (es) | Piperazinas sustituidas sustituidas heterocíclicas para el tratamiento de la esquizofrenia | |
UY26298A1 (es) | "derivados de bencimidazol sustituidos con aminocarbonilo, procedimientos para su preparación y su utilización como medicamentos." | |
CR7735A (es) | Piperizinas heterociclicas sustituidas para el tratamiento de la esquizofrenia | |
UY29078A1 (es) | Amidas del ácido 5 y 6-aminoalquil indol-2-carboxílico 3-sustituidas y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon) | |
ES2193424T3 (es) | Aminas triciclicas farmaceuticamente activas. | |
GT199900078A (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados. | |
PA8579401A1 (es) | Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b | |
ECSP982405A (es) | 2- amino-6 (4- fenoxi -2-sustituido)- piridinas sustituidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |